Tech Company Financing Transactions

PierianDx Funding Round

Health Catalyst Capital Management and private investors joined a $9.3 million Series A venture round for PierianDx. The round was announced on 1/8/2016.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

77 Maryland Plz.
St. Louis, MO 63108
USA

Phone

(314) 628-0035

Website

www.pieriandx.com

Email Address

[email protected]

Overview

PierianDx enables clinical labs to seamlessly manage and interpret complex genetic tests for the most effective patient care. For health systems, children's hospitals, comprehensive cancer centers and reference labs looking to bring next-generation sequencing in-house rapidly or one step at a time.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chairman

Rakesh Nagarajan

        

Chief Executive Officer

Michael Sanderson

        

Chief Medical Officer

Shalini Verma

        

Chief Operating Officer

Chris Callahan

        

VP - Marketing

Josh Forsythe

        

VP - Product Management

Andrew Bredemeyer

        

VP - Product Management

Bryce Daines

        

VP - Product Management

Mukesh Sharma

        

Browse more venture capital transactions:

Prev: 1/8/2016: MMB Networks venture capital transaction
Next: 1/8/2016: Myomo venture capital transaction

Share this article

About Our VC Transactions Data

We do our best to report on funding rounds that are announced publicly. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary